EP1673382A1 - Snp de recepteur adrenergique pour ameliorer les caracteristiques de traite - Google Patents
Snp de recepteur adrenergique pour ameliorer les caracteristiques de traiteInfo
- Publication number
- EP1673382A1 EP1673382A1 EP04784592A EP04784592A EP1673382A1 EP 1673382 A1 EP1673382 A1 EP 1673382A1 EP 04784592 A EP04784592 A EP 04784592A EP 04784592 A EP04784592 A EP 04784592A EP 1673382 A1 EP1673382 A1 EP 1673382A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- milking
- allele
- beta2
- pair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108060003345 Adrenergic Receptor Proteins 0.000 title description 4
- 102000017910 Adrenergic receptor Human genes 0.000 title description 4
- 108700028369 Alleles Proteins 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 20
- 244000309464 bull Species 0.000 claims abstract description 17
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 14
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 11
- 101000959443 Bos taurus Beta-2 adrenergic receptor Proteins 0.000 claims abstract description 8
- 238000012216 screening Methods 0.000 claims abstract description 4
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 30
- 241000283690 Bos taurus Species 0.000 claims description 29
- 241001465754 Metazoa Species 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000523 sample Substances 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 11
- 108091093088 Amplicon Proteins 0.000 claims description 8
- 230000001488 breeding effect Effects 0.000 claims description 7
- 238000009395 breeding Methods 0.000 claims description 6
- 230000002596 correlated effect Effects 0.000 claims description 4
- 101150052147 ALLC gene Proteins 0.000 claims description 3
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 238000009396 hybridization Methods 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 15
- 229930024421 Adenine Natural products 0.000 abstract description 3
- 229960000643 adenine Drugs 0.000 abstract description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract description 3
- 235000013365 dairy product Nutrition 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 208000004396 mastitis Diseases 0.000 description 8
- 239000013615 primer Substances 0.000 description 8
- 210000001082 somatic cell Anatomy 0.000 description 8
- 238000003556 assay Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- 101710152983 Beta-2 adrenergic receptor Proteins 0.000 description 5
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 5
- 244000144980 herd Species 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000003260 vortexing Methods 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 101100378538 Bos taurus ADRB2 gene Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000003161 ribonuclease inhibitor Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- 101150033809 ADRB2 gene Proteins 0.000 description 1
- 101100490566 Arabidopsis thaliana ADR2 gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101100269260 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH2 gene Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000000048 adrenergic agonist Substances 0.000 description 1
- 239000000674 adrenergic antagonist Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 1
- 102000000072 beta-Arrestins Human genes 0.000 description 1
- 108010080367 beta-Arrestins Proteins 0.000 description 1
- 102000015005 beta-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006818 beta-adrenergic receptor activity proteins Proteins 0.000 description 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- -1 nucleotide triphosphates Chemical class 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102220082846 rs373113507 Human genes 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the present invention relates, in general, to the field of molecular biology, human and bovine genetics, and desirable milking characteristics. In particular this invention provides a method for using genetics to predict the milking characteristics of cows.
- Various publications or patent are referred to throughout this application to describe the state of the art to which the invention pertains. Each of this publications or patents is incorporated by reference herein. Complete citations of scientific publications are set forth in the text or at the end of the specification.
- ADRB2 bovine beta2-adrenergic receptor
- a method for breeding cows for improved milking characteristics including the step of screening the genotype of the parents of the cow for the allele associated with a desired SCS phenotype.
- the method has the steps of obtaining a DNA sample from a bull to be tested for the desired SCS phenotype; and detecting the presence of an adenine at position 11 in a gene encoding a bovine beta2-adrenoreceptor.
- the method can be performed by direct sequencing, primer extension, restriction length fragment polymorphism, and allele-specific hybridization.
- a method of identifies a bull whose daughter cows have a short milking duration
- This method has the steps of obtaining a sample of DNA from a bull; combining the DNA with a pair of PCR probes comprising SEQ IDs 1 and 2 or SEQ IDS 3 and 4; incubating the DNA under conditions permitting the DNA bounded by the PCR probes to produce DNA amplicons; isolating the DNA amplicons; combining the DNA amplicons with a restriction enzyme specific for CCCGGG for a sufficient time to produce a mixture of DNA fragments from the amplicons comprising CCCGGG; applying the DNA fragment mixture to a gel and permitting migration of the mixture components for a time sufficient for them to separate; and observing the sizes of DNA on the gel, with the largest fragments being correlated with the A genotype and with better SCS phenotype, and the smaller fragments being associated with the C genotype and less desirable SCS phenotype.
- a milking attribute PCR-RFLP kit contains a pair of primers which flank the 11 th nucleotide position of the bovine beta2-adrenoreceptor gene, and a restriction enzyme specific for the CCCGGG site.
- the restriction enzyme can be Smal.
- the primer pairs are selected from pair 1 (SEQ ID Nos 1 and 2) or from pair 2 (SEQ ID Nos 3 and
- ADR2 bovine beta2-adrenoceptor
- oligonucleotide primers to be used to amplify and perform locus-specific re-sequencing of genomic DNA spanning regions of the bovine ADRB2 gene. These primers were used to amplify genomic DNA from 24 Holstein and 12 Brown Swiss dairy cows. After comparative genomic sequence was obtained, we analyzed the sequence using polyPhred software (Washington University, St. Louis, MO) and identified, among others, a Single Nucleotide Polymorphism (SNP) sequence at position 11, inclusive of the start ATG (hereafter referred to as "Al 1C"). The published sequence indicates the presence of a cytosine (C) nucleotide.
- SNP Single Nucleotide Polymorphism
- This polymorphism was found to be associated with milking characteristics.
- the A allele at the A11C locus is associated with higher somatic cell score (SMS) and therefore with a faster milking speed.
- SMS somatic cell score
- the A allele is effective in both the heterozygous and homozygous conditions to improve the performance of the animal.
- Polymorphism refers generally to the ability of an organism or gene to occur in two or more different forms. In particular for purposes of the present invention, “polymorphism” refers to two or more different forms of the same gene.
- SNP Single Nucleotide Polymorphism
- a “Restriction Enzyme” refers to an endonuclease which bins to double stranded
- Restriction enzymes are denoted by three-letter abbreviations followed by a strain designation and/or a Roman numeral distinguishing different enzymes from the same species or strain. Recognition sequences are written 5' to 3' for one strand only. Examples of restriction enzymes include Smal, BamHi, Bell, EcoRL Hindlll, and Xbal.
- allelic refers generally to any of one or more alternative forms of a given gene or DNA segment; both or all alleles of a given gene are concerned with the same trait or characteristic, but the product or function coded for by a particular allele differs qualitatively and/or quantitatively from that coded for by other alleles of that gene.
- allelic pair i.e., the two alleles of a given gene
- the polynucleotides of the present invention may be prepared by two general methods: (1) They may be synthesized from appropriate nucleotide triphosphates, or (2) they may be isolated from biological sources. Both methods utilize protocols well known in the art. The availability of nucleotide sequence information enables preparation of an isolated nucleic acid molecule of the invention by oligonucleotide synthesis. Synthetic oligonucleotides may be prepared by the phosphoramidite method employed in the Applied Biosystems 37A DNA Synthesizer or similar devices.
- Buffer RLT (Qiagen)(with 10 ⁇ l jS-mercaptoethanol added per 1 ml buffer) was added to the leukocytes; for a starting blood volume of 4.0 ml or less, 2.0 ml was added; and for a greater blood volume, 4.0 ml was added.
- the mixture was homogenized until the sample was homogeneous.
- An equal volume of 70% alcohol was added to the homogenized lysate and vigorously shaken.
- RNA sample purified as described above were added 0.1 volume of 10X DNase I Buffer and 1 ⁇ l of DNase I (2 units) to the RNA, which solution was mixed gently and incubated at 37°C for 20-30 min.
- Ambion DNase Inactivation reagent was resuspended by flicking or vortexing. From that tube, the greater of 0.1 volume or 5 ⁇ l was added to the sample and mixed well. The tube was incubated for 2 min at room temperature. The tube was next centrifuged at 10,000 g for about 1 min to pellet the DNase inactivation reagent.
- RNA concentration was then used to determine RNA concentration, and 1 ⁇ g
- RNA using Omniscript (Qiagen) for Real Time PCR analysis The Omniscript 10X Buffer RT, dNTP mix and RNase-free water were first thawed and mixed by vortexing. Qiagen RNase inhibitor was diluted to a final concentration of 10 units/ ⁇ l in lx Buffer RT and mixed by vortexing briefly. Master mix (2.0 ⁇ l of lOx Buffer RT, 2.0 ⁇ l dNTP mix, 2.0 ⁇ l oligo dT primer (10 uM), 0.5 ⁇ l Rnase inhibitor (10 units/ ⁇ l), 1.0 ⁇ l Omniscript reverse transcriptase and double distilled water) was prepared on ice. Master solution was distributed to the various tubes, and template RNA (0.6 to 0.68 ⁇ l/tube) was added and mixed. The resulting solutions were incubated at 37°C for 60 min.
- Bovine DNAs are available from the Cooperative Dairy DNA Repository
- CDDR CDDR population
- MS milking speed
- Table 2 contains average estimated transmitting abilities (ETA) for
- results from statistical analyses of the data indicate that genotypes AA, AC and CC are significantly different from the mean SCS (p ⁇ 0.025) and that genotypes AA and AC are significantly higher than the mean SCS (p ⁇ 0.01). Furthermore, animals with the CC genotype have significantly different (i.e., lower) SCS phenotypes than animals with AA and AC genotypes (p ⁇ 0.05).
- Table 3 shows the distribution of milking speed (MS) classifications according to genotype
- Table 4 illustrates the average ETA for MS by genotype. Because of the small number of AA animals, there is not a significant association between MS and Al lC genotype at the 5% level. However, the trend in Table 3 clearly shows that the CC genotype has a lower proportion of bulls transmitting fast MS.
- the assay results correlate with the SCS and enable the choice of animals with improved MS and mastitis resistance.
- these discoveries can also be used to select animals in an attempt to effect population changes in MS and mastitis resistance. Applying the assay will enable the selection of animals with SCS which will ultimately improve the herd averages for MS and mastitis resistance.
- This invention also includes a kit containing reagents that can be used to identify allelic composition at the loci described herein.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne un procédé pour dépister l'allèle qui est associé à un phénotype SCS souhaité, consistant : à obtenir un échantillon d'ADN d'un taureau devant être soumis au dépistage du phénotype SCS souhaité, et ; à détecter la présence d'une adénine au niveau de la position 11 d'un gène codant un bêta2-adrénorécepteur bovin. Cette invention concerne en outre un nécessaire d'attributs de traite PCR-RFLP contenant une paire d'amorces qui s'accolent à côté de la 11ème position nucléotidique du gène codant un bêta2-adrénorécepteur bovin, ainsi qu'une enzyme de restriction qui est spécifique du site CCCGGG, et qui peut être l'enzyme SmaI.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50511303P | 2003-09-23 | 2003-09-23 | |
PCT/US2004/030774 WO2005030789A1 (fr) | 2003-09-23 | 2004-09-21 | Snp de recepteur adrenergique pour ameliorer les caracteristiques de traite |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1673382A1 true EP1673382A1 (fr) | 2006-06-28 |
EP1673382A4 EP1673382A4 (fr) | 2006-10-18 |
Family
ID=34392977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04784592A Withdrawn EP1673382A4 (fr) | 2003-09-23 | 2004-09-21 | Snp de recepteur adrenergique pour ameliorer les caracteristiques de traite |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1673382A4 (fr) |
CN (1) | CN100422202C (fr) |
AU (1) | AU2004276248A1 (fr) |
BR (1) | BRPI0414583A (fr) |
CA (1) | CA2539551A1 (fr) |
RU (1) | RU2006113558A (fr) |
WO (1) | WO2005030789A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008140467A2 (fr) * | 2006-09-29 | 2008-11-20 | Pfizer Inc. | Marqueurs génétiques et procédés permettant d'améliorer les caractères de productivité et d'adaptation chez les animaux laitiers |
CN101693923B (zh) * | 2009-11-09 | 2012-02-22 | 山东奥克斯生物技术有限公司 | 筛选耐热性奶牛的HSP70AlA基因SNP位点、应用及试剂盒 |
CN110106250B (zh) * | 2019-05-28 | 2020-11-27 | 中国农业大学 | 与奶牛围产期代谢疾病抗性相关的分子标记及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990010714A1 (fr) * | 1989-03-15 | 1990-09-20 | Wisconsin Alumni Research Foundation | Substance genetique de marquage de vaches laitieres a production superieure de lait |
WO1999019512A1 (fr) * | 1997-10-10 | 1999-04-22 | University Of Cincinnati | POLYMORPHISMES DU RECEPTEUR β-ADRENERGIQUES |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593092B2 (en) * | 2000-04-04 | 2003-07-15 | Abbott Laboratories | Beta 2 adrenergic polymorphism detection |
-
2004
- 2004-09-21 WO PCT/US2004/030774 patent/WO2005030789A1/fr active Application Filing
- 2004-09-21 RU RU2006113558/13A patent/RU2006113558A/ru not_active Application Discontinuation
- 2004-09-21 BR BRPI0414583-6A patent/BRPI0414583A/pt not_active IP Right Cessation
- 2004-09-21 EP EP04784592A patent/EP1673382A4/fr not_active Withdrawn
- 2004-09-21 AU AU2004276248A patent/AU2004276248A1/en not_active Abandoned
- 2004-09-21 CA CA002539551A patent/CA2539551A1/fr not_active Abandoned
- 2004-09-21 CN CNB2004800271385A patent/CN100422202C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990010714A1 (fr) * | 1989-03-15 | 1990-09-20 | Wisconsin Alumni Research Foundation | Substance genetique de marquage de vaches laitieres a production superieure de lait |
WO1999019512A1 (fr) * | 1997-10-10 | 1999-04-22 | University Of Cincinnati | POLYMORPHISMES DU RECEPTEUR β-ADRENERGIQUES |
Non-Patent Citations (1)
Title |
---|
See also references of WO2005030789A1 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0414583A (pt) | 2006-11-07 |
CN100422202C (zh) | 2008-10-01 |
RU2006113558A (ru) | 2007-11-10 |
EP1673382A4 (fr) | 2006-10-18 |
AU2004276248A1 (en) | 2005-04-07 |
CA2539551A1 (fr) | 2005-04-07 |
CN1852916A (zh) | 2006-10-25 |
WO2005030789A1 (fr) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070186298A1 (en) | Follistatin gene as a genetic marker for reproductive and performance traits in pigs | |
JP2011501659A (ja) | 有角および無角ウシの遺伝子マーカーおよび関連する方法 | |
CN101970688A (zh) | 遗传标记和相关上位相互作用的使用方法 | |
MXPA06009452A (es) | Polimorfismos del promotor de leptin y sus usos. | |
AU2009275988B2 (en) | A genetic marker test for Brachyspina and fertility in cattle | |
JP2015526099A (ja) | 乳房炎抵抗性の遺伝子マーカ | |
US10626459B2 (en) | Methods and kits for the identification of animals having a greater potential for desirable characteristics, and for the early identification of fat deposits in bovines | |
MX2007008623A (es) | Marcadores de adn para el crecimiento de ganado. | |
WO2011028134A9 (fr) | Marqueurs biologiques et leurs utilisations | |
Mišeikienė et al. | The influence of TLR4 gene polymorphisms on milk quality and composition of Lithuanian Holstein cows | |
KR101796158B1 (ko) | 돼지의 산자수 예측용 nat9 유전자의 snp 마커 및 이를 이용한 돼지 다산 개체 선발 방법 | |
CA2600677A1 (fr) | Association entre des marqueurs dans un gene de leptine et caracteristique de carcasse dans l'engraissement commercial de genisses et de boeufs | |
US8003328B2 (en) | Bovine polymorphisms and methods of predicting bovine traits | |
Wu et al. | Restriction fragment length polymorphism in the exon 2 of the BoLA-DRB3 gene in Chinese Holstein of the south China | |
US20100009374A1 (en) | Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene | |
WO2005030789A1 (fr) | Snp de recepteur adrenergique pour ameliorer les caracteristiques de traite | |
KR101289484B1 (ko) | 한우 마블링 진단용 유전자 검사 방법 | |
US20070209084A1 (en) | Adrenergic Receptor SNP for Improved Milking Characteristics | |
KR101307008B1 (ko) | 한우 근내지방도 연관 분자표지를 이용한 고급육 생산 한우 진단 방법 | |
KR20110038490A (ko) | 한우 육량 증대 연관 분자표지 개발 및 이를 이용한 고능력 한우 조기진단 방법 | |
Mišeikienė et al. | Utjecaj polimorfizma gena TLR4 na kvalitetu i sastav mlijeka krava holstein pasmine u Litvi | |
MXPA06003211A (en) | Adrenergic receptor snp for improved milking characteristics | |
KR101796160B1 (ko) | 돼지의 산자수 예측용 dact3 유전자의 snp 마커 및 이를 이용한 돼지 다산 개체 선발 방법 | |
KR101280652B1 (ko) | 한우 등지방 관련 유전체 선발 기술 개발 | |
EP2149611A1 (fr) | Test de marqueur génétique pour la brachyspina et la fertilité pour le bétail |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060419 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060914 |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20080103 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20090129 |